Founded in 2002 in New Jersey, US, GenScript Biotech Corporation (GenScript) is a globally recognized biotechnology leader, leveraging proprietary gene synthesis and life-science technologies. Headquartered in Piscataway, US, GenScript operates in over 100 countries and regions. We prioritize our clients' needs and enhance their competitiveness with high-quality, fast, and cost-effective services and innovative products. Our operations are centered around four key platforms: (i) a comprehensive life-science services and products platform, (ii) a biologics CDMO platform, (iii) an industrial synthetic products platform, and (iv) an integrated global cell therapy platform.
The life-science services and products segment offers services and products covering gene synthesis, oligonucleotide synthesis, peptide synthesis, protein production, antibody development, and life-science equipment and consumables. By servicing early-stage research and discovery projects at pharmaceutical, biotech, and academic institutions, our business has made significant contributions to the global life science research community.
LEARN MOREBestzyme Biotech Corporation is a subsidiary of the Group engaged in the synthetic biology fields. Utilizing our advanced enzyme engineering technology, Bestzyme develops innovative products for the feed, alcohol, food, and home care industries. We believe synthetic biology offers us new opportunities from both technical and commercial perspectives.
LEARN MORE
Legend Biotech Corporation is the biopharma subsidiary of the Group that specifically engages in the discovery and development of novel cell therapies for oncology and other indications. Legend's lead product, ciltacabtagene autoleucel, is a chimeric antigen receptor T-cell therapy jointly developed with Janssen Biotech, Inc., for the treatment of multiple myeloma.
LEARN MOREProBio, a subsidiary of GenScript Biotech, offers end-to-end CDMO services from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in CGT, antibody and recombinant protein drug, aiming to accelerate drug development for customers.
LEARN MORE
